G551D Observational Study- Expanded to Additional Genotypes and Extended for Long Therm Follow up (GOAL-e2)

Key facts

Sponsor

Steven M Rowe

Principal Investigator

Steven M Rowe, MD

University of Alabama at Birmingham

Enrollment

120 target

Eligibility

6 years · All sexes

Timeline

2014 – 2021

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Phoenix Childrens Hospital, Phoenix, Arizona, United States
• University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
• Stanford University Medical Center, Palo Alto, California, United States
• The Children's Hospital Colarado, Aurora, Colorado, United States
• National Jewish Health, Denver, Colorado, United States
• Yale, New Haven, Connecticut, United States
• University of Chicago, Chicago, Illinois, United States
• Riley Hospital for Children Indiana University Medical Center, Indianapolis, Indiana, United States
• Indianapolis University, Indianapolis, Indiana, United States
• University of Kentucky, Lexington, Kentucky, United States
• The Johns Hopkins University, Baltimore, Maryland, United States
• Massachusetts General Hospital, Boston, Massachusetts, United States
• Children's Hospital Boston, Boston, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• +15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07071324
  CF Wellness Program
  Johns Hopkins University
• RECRUITINGNANCT07223255
  Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
  Dartmouth-Hitchcock Medical Center
• RECRUITINGNANCT07031323
  OnTrackCF: Engagement, Feasibility, and Acceptability Study
  Boston Children's Hospital
• ACTIVE NOT RECRUITINGNCT07147803
  Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis
  Assiut University
• RECRUITINGPHASE2NCT06998043
  Study With Phage for CF Subjects With Pseudomonas Lung Infection
  BiomX Ltd
• RECRUITINGNCT06683092
  Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
  Boston Children's Hospital
• RECRUITINGPHASE2NCT06559150
  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
  Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
• RECRUITINGPHASE4NCT05704036
  Estrogen Supplementation and Bone Health in Women With CF
  Johns Hopkins University

See all trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome →